Tian Zhang

43PUBLICATIONS
147CO-AUTHORS
Radiation therapyGene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (43)

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Apr 23, 2026
Insurance Disparity in Novel Hormonal Therapy Initiation in Patients With Metastatic Hormone-Sensitive Prostate Cancer: Medicare Advantage Versus Traditional Medicare.

|Mar 27, 2026
Novel Immune Checkpoint Inhibitor and Antibody-Drug Conjugate Approaches in the Perioperative Management of Muscle-Invasive Bladder Cancer.

Joseph Vento, Tian Zhang, Yair Lotan

|Mar 23, 2026
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of renal cell carcinoma, version 3.0.

Rana R McKay, Archana Ajmera, Michael B Atkins

|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

|Jul 28, 2025
Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate Cancer.

Nicolas Sayegh, Zeynep Irem Ozay, Tian Zhang

Pageof 8

Frequent Collaborators

5 joint publications

Andrew J Armstrong

5 joint publications

Daniel J George

5 joint publications

Michael R Harrison

4 joint publications

Matthew I Milowsky